Freudenberg shows strong earnings for fiscal 2024
In fiscal year 2024, Freudenberg had sales of €11,947.5 million, up 0.4 percent compared to the previous year (€11,902.8 million). Exchange-rate effects of €76.9 million, however, had a negative impact on sales. They were mainly shaped by the exchange-rate trend for the Japanese yen and the Brazilian real.
Showing a growth rate of about 4.7 percent, the operating profit of €1,132.4 million was significantly greater than the €1,081.6 million from the previous year. The key success factors have been the company’s innovative product lines as well as its structured expansion into attractive markets and strategic business fields such as medical technology and the energy economy.
Read More